What Happened?
Houston, TX-based Cellenkos-Incorporated Appointed Simrit Parmar as Founder
About the Company
Cellenkos is an early stage clinical biotechnology company that focuses on cord blood-derived T-regulatory cellular therapies for the treatment of autoimmune diseases and inflammatory conditions. Cellenkos is founded on the technologies arising from the laboratory investigations of Simrit Parmar, M.D. Cellenkos` lead product CK0801 delivers clinically meaningful doses of allogeneic cord blood T-regulatory cells to overcome immune dysfunction.
About the Person
Simrit Parmar is Founder at Cellenkos Incorporated. Previously, Simrit held various senior HR leadership roles in the industry.
Info Source
News
Short Profile